At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Biopsy +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study Using Ultrasound for the Detection of Taxane-Induced Peripheral Neuropathy
In Brief
A clinical study evaluating Biopsy, Questionnaire Administration, and 1 other intervention for Peripheral Neuropathy and 12 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This pilot clinical trial studies how well ultrasound works in detecting taxane-induced neuropathy in patients with breast cancer. Ultrasound may work better in diagnosing and detecting neuropathy in breast cancer patients treated with the chemotherapy drug called a taxane.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Neuropathy, Stage 0 Breast Cancer, Stage I Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartMay 2017
Primary CompletionDec 2018
Study CompletionJan 2019
TodayJul 2026
First PostedMay 4, 2017
Enrollment StartMay 11, 2017
Primary CompletionDec 12, 2018
Study CompletionJan 11, 2019
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 9.2 years ago
Interventions
Biopsyprocedure
Undergo skin biopsy
Questionnaire Administrationother
Ancillary studies
Ultrasound Tomographyother
Undergo peripheral nerve ultrasound